openPR Logo
Press release

Chromosomal Aberration Test Market Global Industry Analysis, size, share and Forecast 2018 to 2026(Segmentation by Test Type Mammalian Chromosome Aberration Test Genetic Toxicity Testing Cytogenetic Testing Bacterial Reverse Mutation Test)

03-19-2019 10:52 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Chromosomal Aberration Test Market Global Industry Analysis,

Chromosomal aberration is a structural abnormality in one or more chromosomes. Several mutagenic agents are frequently exposed to the human population, they have potential to damage the DNA. In many cases result in the form of chromosomal aberration. Chromosomal aberration is majorly 4 type deletion, duplication, inversion, and translocation. Induced chromosomal aberrations can be classified into two main classes - chromosome type aberration and chromatids type aberrations. Chromosomal aberration includes rearrangement, breakage and numerical changes which play important role in cancer formation, heritable mutation, developmental abnormalities and embryonic loss. The most common type of chromosomal abnormality is aneyploidy. Chromosomal aberration test procedures importance is increasing with time for determination of genetic risk, DNA, and chromosomal structure changes. Chromosomal aberration tests performed in vitro and in vivo which are designed to detect compounds that include DNA damage. Basically test using mammalian cells is used to identify causative agents of structural changes in chromosomes. Chromosomal aberration test involves the real-time analysis of chromosomes to identify structural and sequential variation.

Increasing awareness about chromosomal aberration test among people suffering from genetic and chromosomal disorders is expected to drive the demand of chromosomal aberration testing market. Growing number of people suffering from genetic disorders are expected to increase demand for chromosomal aberration testing procedures in order to have a healthy baby. Increasing application for chromosomal aberration testing for the diagnosis of disorders like minor disabilities like deafness and cancer expected to create high growth opportunities for chromosomal aberration test market players. Increasing birth abnormalities, adoption of genetic counseling, increasing rate of prenatal diagnosis and fertility treatment are some of the major driving factors of chromosomal aberration test market. Adoption of the point of care testing for quick diagnosis and guiding to doctor are expected to boost the demand of chromosomal aberration testing among healthcare professionals. There are some technical limitations like the higher cost of services, failure to detect abnormal results, standardization and poor test results in case of the contaminated sample. The high cost of testing and limited reimbursement policies is restraining the growth of chromosomal aberration test market.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=1160

The global chromosomal aberration test market is segmented on basis of test type, end user and region:

Segmentation by Test Type
Mammalian Chromosome Aberration Test
Genetic Toxicity Testing
Cytogenetic Testing
Bacterial Reverse Mutation Test
Segmentation by End User
Hospitals
Diagnosis Laboratories
Fertility and Maternity Centers
Research Centers
Chromosomal aberration test is designed to evaluate the potential of test to induce chromosomal abnormalities such as exchanges and breaks. Chromosomal aberration assays are also used to detect chemicals that induce chromosome damage, including complex chromosome change such as rings, exchanges & dicentrics and chromatid & chromosome breaks. The global chromosomal aberration market is expected to witness high growth over forecast period owing to increasing number of the treatment-seeking rate for the genetic problem or avoiding birth defects problems among babies.

Regionally, the global chromosomal aberration test market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China, and Middle East & Africa. North America is expected to lead the global market owing to high awareness among people and presence of several end user providing chromosomal aberration testing services. Europe also shows second largest market in the chromosomal aberration test market due to rising prevalence of genetic problems and chromosomal aberration. However, the chromosomal aberration test market in the Asia-Pacific region is expected to witness significant growth rate in coming years due to increasing investments in fertilities and cancer care, increasing funding by government to curb the prevalence of birth deficiency and genetic disorders.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1160

Some of the players operating in the global chromosomal aberration test market are Charles River Laboratories, Inc., Covance Inc., Molecular Toxicology, Inc., Environmental bio-detection products inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Abbott Laboratories and others.

The report covers exhaustive analysis on:

Chromosomal Aberration Test Market Segments
Chromosomal Aberration Test Market Dynamics
Historical Actual Market Size, 2013 - 2017
Chromosomal Aberration Test Market Size & Forecast 2018 to 2026
Chromosomal Aberration Test Market Current Trends/Issues/Challenges
Competition & Companies involved
Chromosomal Aberration Test Market Drivers and Restraints
Regional Analysis:

North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa
Report Highlights:

Shifting industry dynamics
In-depth market segmentation
Historical, current and projected industry size recent industry trends
Key competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Report Analysis@ https://www.factmr.com/report/1160/chromosomal-aberration-test-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chromosomal Aberration Test Market Global Industry Analysis, size, share and Forecast 2018 to 2026(Segmentation by Test Type Mammalian Chromosome Aberration Test Genetic Toxicity Testing Cytogenetic Testing Bacterial Reverse Mutation Test) here

News-ID: 1661653 • Views:

More Releases from Fact.MR

Remote Control Market Projected to Reach US$ 42.1 Billion by 2034, Growing at a CAGR of 4.8%
Remote Control Market Projected to Reach US$ 42.1 Billion by 2034, Growing at a …
As of right now, estimates place the size of the global remote control market at a 4.8% compound annual growth rate (CAGR) over the following ten years, rising from US$ 26.4 billion in 2024 to US$ 42.1 billion by 2034. Sales of remote controls are expected to increase gradually between 2024 and 2034 as a result of product technical developments and market participants' calculated moves. Businesses have a rare chance to
Global SAP Cloud Platform Services Market is likely to reach a valuation of USD 6.5 Million by 2032
Global SAP Cloud Platform Services Market is likely to reach a valuation of USD …
Fact.MR recently conducted a study on the global SAP cloud platform services market is anticipated to surge from USD 443 million in 2022 to a staggering USD 7,000 million by 2032. This remarkable growth trajectory is projected to unfold at an exhilarating compound annual growth rate (CAGR) of 31% over the period spanning from 2022 to 2032. This analysis delves into pivotal trends shaping the market's growth trajectory. The report elucidates
Mobile Value Added Service Market is projected to rise at a CAGR of 14.9% through 2034
Mobile Value Added Service Market is projected to rise at a CAGR of 14.9% throug …
As per a recent study conducted by Fact.MR, a prominent provider of market research and competitive intelligence, the global Mobile Value Added Service Market is valued at approximately US$ 880.4 million in 2024. Forecasts indicate a robust compound annual growth rate (CAGR) of 14.9% through 2034, with the market anticipated to exceed a valuation of US$ 3,522.6 million by the end of that period. Intense competition among smartphone manufacturers has led
GMP Cell Banking Service Market value is projected to reach US$ 3,123.5 million by 2034
04-23-2024 | Health & Medicine
Fact.MR
GMP Cell Banking Service Market value is projected to reach US$ 3,123.5 million …
According to Fact.MR, a leading provider of market research and competitive intelligence, the global GMP Cell Banking Service Market is anticipated to reach approximately US$ 882.1 million by 2024. Over the period from 2024 to 2034, the market for GMP cell banking services is expected to witness a robust growth rate of 13.7%. The report further forecasts that the market will attain an overall valuation of US$ 3,123.5 million by

All 5 Releases


More Releases for Chromosomal

Chromosomal Microarray Market Trends and Forecast Report 2022 - by Players, Type …
The Global and United States Chromosomal Microarray Market Report has been published by QY Research recently. Chromosomal Microarray Market Analysis and Insights This report focuses on global and United States Chromosomal Microarray market, also covers the segmentation data of other regions in regional level and county level. Chromosomal Microarray market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chromosomal Microarray market will
Doppler Ultrasound Systems find its Use for Obstetrics Imaging; nearly one in 15 …
Doppler ultrasound applications form an essential imaging tool in a range of clinical conditions. Doppler ultrasound which is a noninvasive test has been instrumental in diagnosing poorly functioning valves in the leg veins, a blocked artery, decreased blood circulation into the legs and blood clots and aneurysms. Doppler ultrasound has been used as an alternative to more-invasive procedures—angiography—that involves injecting dye into the blood vessels. These actionable insights are according
07-25-2018 | Health & Medicine
Fact.MR
Global Chromosomal Aberration Test Market Cost Structure, Supply, Demand, Key Re …
Chromosomal aberration is a structural abnormality in one or more chromosomes. Several mutagenic agents are frequently exposed to the human population, they have potential to damage the DNA. In many cases result in the form of chromosomal aberration. Chromosomal aberration is majorly 4 type deletion, duplication, inversion, and translocation. Induced chromosomal aberrations can be classified into two main classes - chromosome type aberration and chromatids type aberrations. Chromosomal aberration includes
In-Vitro Fertilization Market: Chromosomal Defects in Humans Propel Market Growt …
The global in-vitro fertilization market is poised to attain unprecedented growth over the coming years on account of the dexterous efforts of market players. The leading market players are projected to introduce innovative business strategies in order to sustain themselves in the market. Furthermore, the market players are also expected to engage in research and development of novel products that would persuade consumers to resort to in-vitro fertilization. The leading
Preimplantation Genetic Diagnosis Market (Aneuploidy Screening, Chromosomal Aber …
Preimplantation genetic diagnosis (PGD) is the inspection of an embryo in vitro in order to eliminate a genetic condition in case a high risk of that condition is known. PGD is an evolving technique that provides a practical alternative to prenatal diagnosis and termination of pregnancy for couples who are at substantial risk of transmitting a serious genetic disorder to their offspring. Growing incidence of infertility across the world is
Non-invasive Prenatal Testing Market to Grow at 17.50% CAGR from 2014 and 2022 d …
According to the research report’s estimates, the global non-invasive prenatal testing market was worth US$0.5 bn in 2013 and is expected to grow at an incredible CAGR of 17.50% from 2014 to 2022 to reach a figure of US$2.4 bn by 2022. The impressive growth of the global non-invasive prenatal testing market is mainly due to the growing chances of fetuses developing chromosomal disorders such as Down syndrome, Turner syndrome,